Literature DB >> 12825164

Human immunoglobulin as a treatment for West Nile virus infection.

Amy Guillet Agrawal, Lyle R Petersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12825164     DOI： 10.1086/376871

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  23 in total

Review 1.  West Nile virus: a growing concern?

Authors:  L Hannah Gould; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo.

Authors:  Tao Duan; Monique Ferguson; Lintian Yuan; Fangling Xu; Guangyu Li
Journal:  J Antivir Antiretrovir       Date:  2009-11-01

3.  Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

Authors:  Ruchi Srivastava; Chandran Ramakrishna; Edouard Cantin
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

4.  Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

Authors:  John H Beigel; Jeffrey L Nordstrom; Stanley R Pillemer; Cory Roncal; D Ronald Goldwater; Hua Li; P Chris Holland; Syd Johnson; Kathryn Stein; Scott Koenig
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

5.  Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.

Authors:  Serafeim C Chaintoutis; Nikolaos Diakakis; Maria Papanastassopoulou; Georgios Banos; Chrysostomos I Dovas
Journal:  Clin Vaccine Immunol       Date:  2015-07-15

Review 6.  West Nile virus meningoencephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Nat Clin Pract Neurol       Date:  2006-05

7.  Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.

Authors:  L Hannah Gould; Jianhua Sui; Harald Foellmer; Theodore Oliphant; Tian Wang; Michel Ledizet; Akikazu Murakami; Kristin Noonan; Cassandra Lambeth; Kalipada Kar; John F Anderson; Aravinda M de Silva; Michael S Diamond; Raymond A Koski; Wayne A Marasco; Erol Fikrig
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 8.  West Nile virus. Update for family physicians.

Authors:  Michael A Drebot; Harvey Artsob
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

9.  Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice.

Authors:  Kyung Min Chung; Michael S Diamond
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

10.  Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Authors:  Bimmi Shrestha; Bo Zhang; Whitney E Purtha; Robyn S Klein; Michael S Diamond
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.